top of page

Cardiology Ambulatory Surgery Centers: A Complete 2026 Guide

  • 11 minutes ago
  • 12 min read

Only 1.8% of outpatient PCI procedures were performed in ambulatory surgery centers between 2020 and 2022, yet ASC use rose from 0.01 to 0.87 procedures per 10,000 person-years between 2018 and 2022, according to a nationwide study of 408,060 patients (EurekAlert summary of the study). That combination matters more than either figure alone. Cardiology's migration into outpatient settings is real, but it remains selective, uneven, and highly dependent on case selection, market structure, staffing, and transfer readiness.


Hospital executives shouldn't treat cardiology ambulatory surgery centers as a universal replacement for hospital outpatient departments. The stronger question is narrower and more useful: which cardiovascular cases can move safely, which markets can support the model, and which staffing structure can operate it without shifting complexity into the emergency department?


Table of Contents



Why Cardiology Is Moving Into Ambulatory Surgery Centers


Cardiology procedures performed in ASCs grew from 55 facilities in 2018 to 221 in 2023. In the same year, about 6,300 ASCs treated 3.4 million fee-for-service Medicare beneficiaries and generated approximately $6.8 billion in Medicare and beneficiary spending, according to the MedPAC report. The platform is already substantial. Cardiology adds a higher operational burden because patient selection, staffing, anesthesia, recovery, and emergency transfer must work together.


Three forces are pushing selected cardiac procedures outpatient. Physicians want tighter control over planned procedural pathways. Patients prefer same-day care when their condition permits it. Payers continue to examine the cost difference between freestanding facilities and hospital departments. CMS added cardiovascular procedures to the ASC pathway for 2026, creating a payment route for selected electrophysiology and interventional cardiology cases that previously required a different site-of-service strategy. The ASC Association summary of the 2026 final payment rule outlines the change.


A graphic showing the transition of cardiac procedures from traditional hospitals to ambulatory surgery centers by 2026.


The board-level questions


A credible business case must answer three questions before leaders order equipment or sign physician agreements:


  • Which cases belong there? Stable, elective, protocol-driven cases fit a different operating model from unstable patients, complex anatomy, or procedures likely to require prolonged monitoring.

  • Which markets can support it? Payer mix, procedural volume, specialist availability, and a nearby transfer hospital matter more than national growth projections.

  • Which staffing model will carry the risk? Cardiac-trained registered nurses, electrophysiology-capable teams, anesthesia coverage, and dependable physician availability are required operating capacity.


Medicare ASC surgical procedure volume per fee-for-service beneficiary increased 5.7% in 2023, according to MedPAC's analysis. That growth does not validate every cardiac ASC. It shows that executives are making site-of-service decisions within a growing outpatient platform. The winning programs define their case mix, staffing model, and transfer limits before they buy technology.


What a Cardiology ASC Actually Is


A cardiology ASC is a freestanding, procedure-focused facility designed to admit, treat, recover, and discharge selected patients without an overnight hospital stay. It isn't just a hospital cath lab with fewer beds, and it isn't interchangeable with an office-based lab. The operating model, regulatory obligations, emergency planning, and clinical scope differ.


An office-based lab generally operates inside a physician practice with a narrower regulatory and procedural framework. A hospital outpatient department remains hospital-owned and connected to broader inpatient resources. A cardiology ASC occupies the middle ground, with dedicated procedural infrastructure and CMS certification for eligible outpatient services. A practical overview of ASC structure and setting distinctions is available in this explanation of what an ambulatory surgery center is.


An infographic illustrating the differences between Office-Based Labs, Hospital Outpatient Departments, and Cardiology ASCs in healthcare settings.


The cases that fit


The appropriate case mix depends on physician judgment, facility capability, payer rules, and a written selection protocol. Commonly considered categories include:


  • Diagnostic catheterization: Planned diagnostic studies in stable patients with a defined recovery pathway.

  • Percutaneous coronary intervention: Selected PCI for stable patients, provided the center can manage access-site complications, ischemic events, sedation needs, and rapid transfer.

  • Device procedures: Certain pacemaker or defibrillator-related procedures may fit when patient risk and device complexity remain within the center's capability.

  • Electrophysiology studies: Diagnostic EP work can be appropriate when post-procedure monitoring and escalation criteria are explicit.

  • Catheter ablation: Same-day atrial fibrillation ablation is now part of the outpatient conversation, but only for patients who meet strict clinical and operational criteria.


The suitable patient is generally stable, elective, medically optimized, and unlikely to require extended observation. Recent decompensated heart failure, unstable ischemia, advanced mechanical circulatory support, uncontrolled comorbidity, or anticipated overnight monitoring should push the case toward a hospital.


Practical rule: A case belongs in an ASC only when the clinical risk, recovery pathway, and transfer plan are all predictable.

The distinction is simple in principle. An OBL is often appropriate for narrower office-based interventions, an ASC for eligible procedures requiring dedicated surgical or cardiac infrastructure, and a hospital for cases whose complexity exceeds same-day recovery and transfer capacity.


The 2026 CMS Rule Changes That Reshaped the Economics


The 2026 rule changes turn outpatient cardiology into a case-level payment decision. CMS added electrophysiology and PCI codes to the ASC-covered procedure pathway, including 93619, 93620, 93642, 93650, 93653, 93654, 93656, 93724, C9602, C9604, and C9607.


The electrophysiology additions include catheter ablation codes for procedures such as pulmonary vein isolation. The interventional additions include PCI codes, giving operators a clearer reimbursement path for selected coronary cases outside the hospital outpatient department. Coverage does not remove clinical exclusions, payer authorization requirements, or facility obligations. It gives eligible cases a payment framework that can be modeled.


CPT Code

Procedure

Payment information

Operating implication

93656

Pulmonary vein isolation ablation

ASC payment: $20,256. HOPD payment: $26,704

HOPD payment is $6,448 higher, so volume, staffing, and recovery costs determine whether the ASC margin works

93653, 93654, 93650

Catheter ablation procedures

Final payment varies by case and payer

Confirm authorization, payer-specific rates, anesthesia needs, and recovery capacity before scheduling

C9602, C9604, C9607

PCI procedures

Final payment varies by case and payer

Model each case using lesion complexity, supply cost, access-site risk, transfer readiness, and expected recovery time


The clearest comparison is CPT 93656. The finalized ASC payment is $20,256, while the hospital outpatient payment for intracardiac ablations is $26,704, a difference documented in Boston Scientific's 2026 OPPS and ASC final-rule reimbursement memorandum.


What finance teams should do


Finance teams should build a contribution-margin model for each procedure and payer, not judge the opportunity from the fee schedule alone. Include physician compensation, anesthesia, implants, supplies, nursing and technical staffing, authorization work, recovery time, transfer readiness, and canceled-case exposure. The model should also show the minimum weekly volume needed to support the schedule and the fixed cost of maintaining cardiac capability.


A code may be ASC-covered and still lose money. Low utilization, expensive disposable supplies, prolonged recovery, or hospital-level staffing held on standby can erase the payment advantage. Leaders should validate the assumptions with actual case times, supply invoices, denial patterns, and transfer drills before expanding the service line.


Start with cases that have standardized pathways, controlled supply costs, predictable recovery, and limited inpatient backup needs. Complex PCI, unstable coronary syndromes, high-risk ablation, and cases likely to require prolonged observation remain hospital work unless the program has unusually strong infrastructure and a validated selection process. The rule expands the addressable menu, it does not make every newly covered code suitable for an ASC.


Regulatory and Accreditation Stack


A cardiology ASC clears compliance in layers. The sequence matters because leaders often spend time on accreditation or equipment before confirming that the state will permit the facility or procedure to operate.


Federal requirements come first. CMS establishes ASC definitions and participation requirements in 42 CFR 416.2 and 42 CFR 416.40–49, including health and safety conditions that facilities must satisfy for participation (CMS ASC conditions and standards). These requirements shape governance, nursing services, medical oversight, patient rights, quality assessment, infection control, emergency preparedness, and documentation.


A diagram illustrating the regulatory and accreditation requirements for a cardiology ambulatory surgery center.


State approval can stop the project


State certificate-of-need rules remain a practical barrier in many markets. A state may require approval for the facility, the service line, additional operating capacity, or related hospital partnership arrangements. Executives should conduct a state-specific legal and regulatory review before committing to a site, because federal eligibility doesn't override state restrictions.


The next layer is accreditation. Organizations commonly evaluate AAAHC, AAAASF, or The Joint Commission based on payer requirements, state expectations, governance preferences, and the scope of services. Accreditation should be treated as an operating discipline, not a marketing badge. Survey readiness exposes weaknesses in credentialing, medication management, emergency drills, infection prevention, and quality reporting.


A structured healthcare credentialing process is essential because cardiac privileges must match actual training, procedural experience, call coverage, and transfer responsibilities. Credentialing a physician for a procedure without confirming the facility's ability to support that physician creates a governance failure.


Specialty-specific measurement


The American College of Cardiology's CV ASC Registry Suite adds procedure-level measurement for hospitalization, emergent transfer, medications, efficiency, adverse events, and bleeding events (ACC announcement of the CV ASC Registry Suite). That matters because generic outpatient benchmarks can conceal cardiac-specific risk.


The practical sequence is straightforward:


  1. Confirm federal CMS eligibility and conditions.

  2. Resolve state licensing and certificate-of-need questions.

  3. Select an accreditation pathway aligned with payer and state requirements.

  4. Begin cardiac-specific outcome tracking before volume expands.


Facility, Equipment, and Transfer Requirements


The facility must be designed around the worst credible complication, not the average uncomplicated discharge. A cardiac ASC needs a procedure room capable of supporting its approved case mix, imaging equipment appropriate to the intervention, cardiovascular monitoring, recovery capacity, emergency power, medication systems, and a transfer pathway that works at the time of day the procedure occurs.


For interventional cardiology, that usually means a dedicated cath lab with single-plane or biplane imaging, fluoroscopy, real-time hemodynamic monitoring, radiation protection, contrast management, and sterile processing. Electrophysiology programs require additional mapping, ablation, recording, and device infrastructure based on the procedures approved. Equipment selection should follow the case mix, not vendor enthusiasm.


An infographic detailing facility, equipment, and transfer requirements for cardiac procedures, including imaging and transfer protocols.


The nonnegotiable dependencies


  • Cardiac resuscitation: Crash carts, defibrillation capability, emergency medications, airway equipment, and staff drills must match cardiovascular emergencies.

  • Power and continuity: Emergency generation and backup systems must support imaging, monitoring, ventilation, refrigeration, communications, and safe patient movement.

  • Recovery capacity: The PACU needs nurses comfortable with access-site management, rhythm surveillance, sedation recovery, bleeding assessment, and escalation decisions.

  • Transfer execution: A written agreement is only the beginning. The center needs defined acceptance contacts, ambulance access, communication protocols, transfer documentation, and a tested route to the receiving hospital.

  • Sterile processing: Instrument turnaround, implant handling, infection prevention, and contingency planning must support the scheduled case mix without creating unsafe delays.


The transfer agreement is not the safety plan. The safety plan is the agreement plus trained people, reliable communications, and rehearsed execution.

Capital costs and specialist supply are common launch blockers even after CMS makes a procedure eligible. Industry analysis also identifies high capital costs, staffing limitations, and state-by-state regulation as persistent obstacles to expansion (CVL's 2026 cardiology outlook).


Build now, phase later


Day-one requirements include emergency power, cardiac monitoring, resuscitation equipment, imaging, sterile processing, PACU capability, medication security, transfer processes, and trained staff. Additional procedure platforms, advanced imaging, or broader service lines can be phased in only after utilization, competency, payer access, and quality data support the expansion.


Staffing Models for Cardiac ASCs


The staffing model determines whether a cardiac ASC operates as a focused procedural service or an expensive miniature hospital. The right structure depends on volume, physician ownership, case complexity, and whether cardiology is the center's only specialty.


A single-specialty ASC often benefits from employed physicians or a closely aligned professional services structure. Employment gives the organization control over scheduling, credentialing, quality participation, and case selection. The tradeoff is fixed compensation exposure when volume is immature.


A hybrid model can combine employed clinical leadership with independent cardiologists who bring referral volume and procedural expertise. It can work well when governance is explicit. The operating agreement should define block allocation, quality obligations, supply decisions, call responsibilities, peer review, and the consequences of poor attendance or low throughput.


A hospital joint venture offers access to capital, transfer infrastructure, contracting support, and institutional credibility. It can also introduce slower decision-making and competing priorities. Hospital participation is useful when the transfer relationship, payer strategy, or capital requirement exceeds what physicians can reasonably carry alone.


The perioperative layer


Registered nurses need experience with cardiac monitoring, access-site complications, sedation recovery, and escalation. EP programs should prioritize staff familiar with electrophysiology lab workflow, mapping systems, ablation equipment, and post-ablation observation. Scrub technologists must understand device and catheter inventory, sterile technique, and procedure-specific emergencies.


Advanced practice providers can create the operating efficiency that keeps the program appropriately staffed. NPs and PAs can manage pre-admission testing, medication reconciliation, patient education, discharge criteria, follow-up calls, and selected recovery workflows under the program's clinical governance.


Anesthesia coverage should match the planned sedation and procedure profile. The center must define which cases require an anesthesiologist, which can use a certified registered nurse anesthetist under the applicable model, and who owns airway and hemodynamic escalation.


Locums should bridge, not define


Locum tenens coverage can protect a launch when recruitment is incomplete or a physician is unavailable. It shouldn't become the permanent answer for core procedural leadership. Long-term reliance weakens culture, complicates credentialing continuity, and makes scheduling and quality accountability harder.


Recruiting and Retaining Cardiac Specialists


Cardiac ASC recruitment requires a different value proposition from hospital recruitment. The candidate isn't evaluating compensation and clinical prestige. The candidate is assessing schedule control, call exposure, case-mix quality, governance, procedural volume, and whether the center has the staff and infrastructure to support safe work.


The national shortage of cardiac physicians makes poorly designed searches expensive. A recruiting strategy should begin with a precise role definition, including procedural privileges, expected case mix, transfer responsibilities, employment or partnership structure, APP support, and the relationship with the hospital partner.


What closes the right candidate


  • Predictable scheduling: Elective ASC work can offer greater control than a hospital role, but only if block time, turnover expectations, and cancellation policies are realistic.

  • Limited inpatient burden: Candidates may value a role that reduces inpatient call, provided escalation pathways and hospital coverage are clearly assigned.

  • Equity or governance: Joint-venture opportunities can attract physicians who want influence over equipment, staffing, supply chain, and case selection.

  • Clinical support: A cardiac specialist won't stay in a program that lacks experienced nurses, trained technologists, anesthesia reliability, or rapid hospital access.

  • Protected quality work: Physicians need time and authority to review transfers, complications, cancellations, and near misses.


Contingency recruiting can work for more accessible roles, but difficult interventional cardiology and electrophysiology searches usually require retained attention. The search partner must understand cardiac subspecialty language, credentialing requirements, procedural scope, and the difference between a hospital-based candidate and an ASC-ready candidate. Organizations evaluating that distinction can review physician placement agencies and their role.


Retention follows operating discipline


Compensation won't repair a chaotic schedule or unsafe throughput target. Leaders should protect retention by controlling case mix, publishing escalation rules, maintaining adequate nursing coverage, and using quality data in physician governance rather than treating every complication as an individual performance issue.


A strong retention plan also gives specialists a credible path to influence. Physicians should participate in selection criteria, peer review, registry interpretation, equipment planning, and transfer-protocol updates. That involvement turns the ASC from a room-and-equipment project into a clinical program worth staying with.


When a Cardiology ASC Makes Sense and When It Does Not


A cardiology ASC makes sense when four conditions align: the case mix is predictable, the market can support the volume, the payer environment supports the economics, and the transfer hospital can absorb emergencies without friction. Remove one of those conditions and the program deserves a harder review.


The strongest market usually has established interventional or electrophysiology specialists, adequate referral density, commercial and Medicare contracting access, experienced cardiac nurses, and a hospital partner close enough to support urgent transfer. The center should also have a defined low-risk case mix that can be scheduled consistently rather than a broad promise to perform “cardiology.”


An ASC becomes a financial trap when leaders build for projected demand without confirming physician supply, payer authorization, equipment utilization, or patient suitability. Thin commercial payer mix can weaken margins. Certificate-of-need restrictions can delay or prevent expansion. Capital constraints can force underpowered infrastructure. An aging or medically complex population may generate cardiovascular demand without generating enough patients who fit elective same-day pathways.


Industry coverage identifies persistent barriers including prior authorization, documentation burden, and capital constraints, while Pennsylvania ASC visit volume fell 4.8% year over year in fiscal year 2024, demonstrating that procedural expansion doesn't automatically create broad volume growth in every market (ASC News analysis).


A practical go or no-go screen


Question

Proceed when

Stop or redesign when

Case mix

Stable, elective, protocol-driven cases dominate

High-risk and observation-heavy cases drive the plan

Market

Specialists, referrals, and payer access are established

Volume depends on uncommitted physicians or weak contracting

Transfer

Hospital acceptance and transport are tested

The agreement exists only on paper

Workforce

Cardiac nurses, EP staff, APPs, and anesthesia are available

Staffing depends permanently on locums or borrowed hospital teams

Economics

Contribution margin remains positive after full staffing and supply costs

Reimbursement is modeled without authorization, cancellations, or emergency readiness


Executives should track five metrics in year one:


  1. Case throughput, which reveals scheduling, turnover, and staffing failure.

  2. Emergent transfer rate, which tests selection criteria and escalation readiness.

  3. Complication rate, including bleeding and adverse events, which identifies clinical risk.

  4. Cost per case, which exposes supply, labor, and underutilization problems.

  5. Physician retention, which shows whether governance, workload, and infrastructure are credible.


The correct decision isn't whether cardiology will move outpatient. It will, selectively. The decision is whether a specific organization can move the right cases with the right people, in the right market, without pretending that an ASC has hospital resources it doesn't possess.



American Cardiology Group supports hospitals, health systems, cardiac ASCs, and physician practices with permanent physician recruitment, locum coverage, APP placement, and cardiac leadership searches. Leaders planning ambulatory cardiac expansion can visit American Cardiology Group to discuss staffing requirements for interventional cardiology, electrophysiology, cardiac surgery, and perioperative teams.


 
 
 

Comments


bottom of page